We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Graffinity and Elan Launch Fragment-Based Drug Discovery Collaboration

News   Jan 29, 2009

 
Graffinity and Elan Launch Fragment-Based Drug Discovery Collaboration
 
 
 

RELATED ARTICLES

High-throughput Platform Enables Activity Mapping of Emerging Cancer Drug Targets

News

A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for cancer treatment.

READ MORE

Immune System on a Chip Launched to Space

News

Research on the ISS National Lab is creating unprecedented opportunities for scientists to study microgravity-induced changes in human physiology relevant to diseases here on Earth, and accelerates the development of translational technologies for earthly applications.

READ MORE

Universal Cancer Test: One Test to Diagnose Them All?

News

A diagnostic test is in the works to identify patterns of methyl groups, which are altered dramatically by cancer. The test uses gold nanoparticles that instantly change colour and indicate if the nanostructures of cancer DNA are present.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE